RTI Surgical Holdings Inc. (RTIX)

2.83
NASDAQ : Health Technology
Prev Close 2.69
Day Low/High 2.74 / 2.90
52 Wk Low/High 2.50 / 6.15
Avg Volume 131.30K
Exchange NASDAQ
Shares Outstanding 73.90M
Market Cap 198.05M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

RTI Biologics Announces 2010 First Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2010 as follows: Quarterly Overview: ...

RTI Biologics Announces 2010 First Quarter Earnings And Conference Call

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading processor of orthopedic and other biologic implants, will be releasing financial results from the first quarter on Wednesday, April 28, 2010 before the market opens.

RTI Biologics Launches Reimbursement Hotline For Sports Medicine

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has entered into an agreement with Reimbursement Principles Inc.

RTI Biologics™ Launches Two Biologic Implants At Orthopaedic Surgeon Annual Meeting

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries ...

RTI Biologics Donates Matrix HD™ For Surgeries In Haiti

RTI Biologics Donates Matrix HD™ For Surgeries In Haiti

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage ...

RTI Biologics' Matrix HD(TM) Terminally Sterlized Dermis Allograft. (Photo: Business Wire)

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated a sterilized dermis allograft, Matrix HD ™, to treat an eight-year ...

RTI Biologics 1Q Profit Climbs 60 Percent

RTI says 1st-quarter profit rose following Tutogen acquisition, and specialty sales improved

Health Winners & Losers: Genentech

Genentech climbs on news that Roche's buyout offer isn't a done deal.

Tuesday's Winners and Losers: Apple

The tech company's shares climb on strong sales of the iPhone in Europe.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Tutogen climbs on a merger deal with Regeneration Technologies.

Tuesday's Health Winners & Losers

Regeneration Technologies climbs after swinging to a quarterly profit.

Health Stocks in Motion

America Service shares plummet after the company announces an internal investigation.

Health Stocks in Motion

Health Stocks in Motion

Regeneration Tech falls on weak quarter.

Rescue Effort on Dollar Doesn't Save Stocks

The Bank of Japan's support for the dollar failed to turn around a down day for stocks.

Regeneration Technologies Sheds 33%

Shares take a dive after the company says third-quarter revenue would miss forecasts.

Regeneration Technologies Cuts Revenue Outlook

The company cites lower-than-expected orders for its spinal implants.

Some Insiders Sending a Bullish Signal

Data maven George Muzea says several sectors show bullish signs. Plus, CryoLife, Peregrine and Pre-Paid.

Stocks to Watch: First Data Rises, While Adobe Drops

Stocks to Watch: First Data Rises, While Adobe Drops

Also, Steel Dynamics and ScanSoft are up, but Regeneration Tech and ICN fall.

TheStreet Quant Rating: C- (Hold)